| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |